What are you looking for? Search Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients, Fulltext search Tipus de contingut Services and units Professionals Pathologies Health advices Health and wellness Diagnostic tests Treatments News Activities Centers - Any - Search Professionals Gerard Cantero Recasens I am a Principal Investigator of the Renal Physiopathology Group at Vall d'Hebron Research Institute (VHIR) in Barcelona. Motivated by my deep interest in understanding how ion signalling impacts cellular homeostasis and its pathological implications, I have cultivated over the years a diverse skill News Vall d'Hebron redesigns its brand to harmonise the Campus, Hospital and Research Institute logos The redesign aims to apply the successful Campus image line to the Hospital and the Research Institute. Professionals David Humberto Marmolejo Castañeda Name: David Humberto Marmolejo Castañeda Date of birth: August 31st/1989 Place of birth: Cali, Colombia Country of Citizenship: Colombia Activities Curso de especialista en gestión administrativa de Ensayos Clínicos (CTA) ¿Qué es un CTA? El Clinical Trial Assistant (CTA) es un perfil administrativo especializado en la gestión de ensayos clínicos, que se encarga tanto de la presentación de los estudios en el CEIm y autoridades competentes, como del apoyo al equipo investigador, Clinical R Activities Diagnóstico Molecular para residentes de alergia Más información: https://aula.vallhebron.com/index.php?go=info_cursos&curso=644 Aula Vall d'H News Renal cell metabolism in diabetic men predisposes to renal disease An international study involving the Hospital del Mar Research Institute and VHIR shows that there are substantial differences between men and women in the energy metabolism of of renal tubular cells. Activities Cáncer en el adolescente y adulto joven (AYA): Del diagnóstico precoz al seguimiento a largo plazo Más información: https://aula.vallhebron.com/?go=info_cursos&curso=658&idioma=es Aula Vall d'Hebron Secretaría Técnica actividades formativas externas Mail: inscripcions@aulavallhebron.cat tel: 693.785.436 News Vall d'Hebron participates in an international clinical trial that has led to approval of the first drug for advanced fatty liver disease Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver. Activities III Curso formación en Simulación clínica en Alergia Más información: https://aula.vallhebron.com/?go=info_cursos&curso=641&idioma=es ECMO Program An opportunity for some patients with heart failure or severe respiratory disease for whom conventional therapeutic measures are no longer effective. A multidisciplinary team of experts and state-of-the-art technologies provide extracorporeal life support, with a better clinical context and more Pagination Previous page ‹‹ Page 221 Next page ››